Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.09%||69.71||1.0%||$515.13m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.68%||206.61||1.9%||$454.10m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.98%||654.04||2.7%||$419.38m|
|SNSS||Sunesis Pharmaceuticals, Inc.||1.16%||4.36||0.7%||$304.78m|
|EXAS||EXACT Sciences Corp.||3.48%||86.26||18.0%||$150.95m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.62%||88.38||4.2%||$138.75m|
Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers in October 9, 2014 and is headquartered in Miami, FL.